60% HFD Induced Obesity (DIO) models

Obesity Models and Efficacy Services
60% HFD Induced Obesity (DIO) models45% HFHSD Induced Obesity(DIO) modelsC57BL/6-Alms1-delWild Mouse 750
Type II Diabetes Models and Efficacy Service
BKS-dbHFHSD+STZ Induced Diabetes Models
Liver Disease Models and Efficacy Services
CCl4-induced Liver Fibrosis ModelsHFD+CCl4-induced NASH ModelsBKS-db NASH ModelsB6-Alms1-del NASH ModelsOther NASH Models
Atherosclerosis Models and Efficacy Services
ApoE KO ModelsLdlr KO Models
Hyperlipidemia Models and Efficacy Services
hPCSK9-UTR ModelshPCSK9 Models
Gout/Hyperuricemia Models and Efficacy Services
Monosodium Urate (MSU)-induced Gouty Arthritis ModelsUrate Oxidase Knockout (Uox-KO) Gout Models

Study Outline

Fig1.png

Figure 1. HFD: 60% high-fat diet; HFHSD: 45% high-fat, high-sugar diet. Experimental period: 12-20 weeks.


Data Validation

1. Body weight curve

Fig2.png

Figure 2. 60% high fat feeding caused rapid increase of body weight of C57BL/6J mice. Data are presented as Mean±SEM.**, p<0.01;***, p<0.001 vs control by unpaired two-tailed Student's t-test.


2. Glucose tolerance test

Fig3.png

Figure 3. Control and DIO mice (feeding HFD for 12 weeks) were fasting for 6 hours and then gavaged with 2g/kg glucose solution. Blood glucose was measured at 0, 15, 30, 60, 90 and 120 min after glucose gavage. The glucose tolerance of DIO mice was significantly impaired when compared with control mice. Data are presented as Mean±SEM. ***, p<0.0001 vs control by unpaired two-tailed Student's t-test.***，P<0.001.


3. Serum insulin level

Fig4.png

Figure 4. After 6 hours of fasting, insulin levels were measured at 0 and 15 min in the oral glucose tolerance test. Insulin levels of DIO mice were significantly higher than those in the control group. Data are presented as Mean±SEM. ***, p<0.001 vs control by unpaired two-tailed Student's t-test.


Efficacy data

1. Orlistat significantly reduced the body weight of DIO mice

Fig5.png

Figure 5. Orlistat significantly reduced the body weight of DIO mice. Data are presented as Mean±SEM. n=10 for each group.


2. Orlistat significantly reduced the body fat ratio of DIO mice

Fig6.png

Figure 6. Orlistat significantly reduced the body fat ratio of DIO mice after 28 days treatment. Data are presented as Mean±SEM.***, p<0.001 by one way ANOVA with Tukey’s post unpaired hoc test.


3. Orlistat significantly reduced the serum leptin and insulin levels of DIO mice

Fig7.png

Figure 7. Orlistat significantly reduced the serum leptin and insulin levels of DIO mice after 28 days treatment. Data are presented as Mean±SEM.***, p<0.001 by one way ANOVA with Tukey’s post hoc test.


TALK WITH OUR EXPERTS

GemPharmatech is committed to protecting and respecting your privacy, and we'll only use your personal information to administer your account and to provide the products and services you requested from us. From time to time, we would like to contact you about our products and services, as well as other content that may be of interest to you. If you consent to us contacting you for this purpose, please click below to say how you would like us to contact you:

In order to provide you with the content requested, we need to store and process your personal data. If you consent to us storing your personal data for this purpose, please click the checkbox below.

You can unsubscribe from these communications at any time. For more information on how to unsubscribe, our privacy practices, and how we are committed to protecting and respecting your privacy, please review our Privacy Policy.